National Clinical Trials



National Ophthalmic Genotyping Network (eyeGENE)

Age Related Eye Disease Study II (AREDS II)

Lucentis plus Sirolimus for AMD (EMERALD)

Lucentis plus Volociximab for AMD (OPTHOTECH)

High Dose Lucentis for AMD (HARBOR)

Lucentis for Retinal Vein Occlusion (HORIZON)

Lucentis vs Avastin for AMD (CATT)

Lucentis for Diabetic Macular Edema (RISE)

Lucentis to Prevent PRP-Induced Retinal Edema (PRIME)

Microplasmin for non-surgical treatment of Vitreomacular Traction Syndrome (Thrombogenics)


Lucentis for Branch Retinal Vein Occlusion (BRAVO)

Lucentis for Central Retinal Vein Occlusion (CRUISE)

Lucentis for AMD for Patients Previously Enrolled in MARINA/FOCUS Trials (HORIZON)

Diabetic Retinopathy Clinical Research Trial: IVT vs. Grid Laser (DRCR)

Standard Care vs. Corticosteroid for Retinal Vein Occlusion Study (SCORE)

Lucentis for AMD (SAILOR)

Lucentis/Visudyne (DENALI)

Phase I/II Study of Lucetis/Visudyne for AMD (FOCUS)

Phase III Study of Lucentis for AMD (MARINA)

Visudyne/IVT vs. Visudyne/Macugen for AMD (VERITAS)

Visudyne for Minimally Classic AMD (VMC)


ASPEN Study for Non-insulin Dependant DM


Complications of Age Related Macular Degeneration Trial Prevention Trial (CAPT)

CNVPT Pilot Study

Submacular Surgery Trial (SST)


Radiation Treatment For AMD

Interferon for AMD

Collaborative Ocular Melanoma Study (COMS)